BlackRock, Inc. 13D and 13G filings for VYNE Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-09 6:05 pm Purchase |
2021-06-30 | 13G | VYNE Therapeutics Inc. VYNE |
BlackRock Inc. BLK |
57,649 2.000% |
57,649 (New Position) |
Filing |